Long term adverse effects related to nucleoside reverse transcriptase inhibitors: Clinical impact of mitochondrial toxicity

Differential gene expression indicates that ‘buffalo hump’ is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy

(2009) Jordi P Guallar et al.   AIDS

Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment

(2009) Richard H Haubrich et al.   AIDS

Mitochondrial DNA Content, an Inaccurate Biomarker of Mitochondrial Alteration in Human Immunodeficiency Virus-Related Lipodystrophy

(2008) M. J. Kim et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of Reducing the Dose of Stavudine on Body Composition, Bone Density, and Markers of Mitochondrial Toxicity in HIV‐Infected Subjects: A Randomized, Controlled Study

(2008) G. A. McComsey et al.   CLINICAL INFECTIOUS DISEASES

Hemochromatosis Gene Polymorphisms, Mitochondrial Haplogroups, and Peripheral Lipoatrophy during Antiretroviral Therapy

(2008) Todd Hulgan et al.   JOURNAL OF INFECTIOUS DISEASES

Distinct Mechanisms for Mitochondrial DNA Loss in T and B Lymphocytes from HIV‐Infected Patients Exposed to Nucleoside Reverse‐Transcriptase Inhibitors and Those Naive to Antiretroviral Treatment

(2008) Anne Maagaard et al.   JOURNAL OF INFECTIOUS DISEASES

Mechanisms of Zidovudine-Induced Mitochondrial Toxicity and Myopathy

(2008) Erin R. Scruggs et al.   PHARMACOLOGY